Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities
Funding Amount
$1,920,000 total
Deadline
Forecast — dates not yet posted
Number of Awards
4
Grant Type
Federal
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Public colleges & universities
- Private colleges & universities
Overview
The National Institute of Biomedical Imaging and Bioengineering intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to enhance bioengineering and imaging research capacity, technology innovation, education and research training, and opportunities for scientific growth at Historically Black College and Universities (HBCUs). The planned NOFO aligns with the HBCU PARTNERS Act (Public Law 116-270) and Executive Order 14283, which seek to strengthen capacity and competitiveness of HBCUs; align HBCUs with educational and economic competitiveness priorities of the United States; encourage HBCU participation and competitiveness for Federal research and development funding through grants, contracts, and cooperative agreements; and foster public-private partnerships to promote centers of academic research and program excellence at HBCUs. Applications are not being solicited at this time. This Notice is being provided to allow potential applicants time to develop meaningful collaborations and responsive projects. This NOFO will utilize the UG3/UH3 activity code. HBCUs, defined as institutions listed in 34 C.F.R. § 608.2 , will be eligible to apply. Investigators with expertise in bioengineering, biomedical imaging, and technology development are encouraged to consider applying for this NOFO. Collaborative investigations combining expertise in bioengineering, imaging, and technology development with disease- or discipline-specific expertise in other areas of biomedical investigation will also be encouraged.
Details
- Agency: National Institutes of Health
- Department: Department of Health and Human Services
- Opportunity #: RFA-EB-26-003
- Total Funding: $1,920,000
- Expected Awards: 4
- Instrument: cooperative_agreement
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Clinical Centers (U01 Clinical Trial Required)
National Institutes of Health
Amount
Up to $1M
Deadline
October 9, 2026
Optimal Treatment Strategies for use of Anti-Obesity Medications (AOMs) in Children and Adolescents Research Coordinating Center (U24 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 9, 2026
Development and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
$650,000 total
Deadline
October 9, 2026
Addressing Methodological Challenges with Clinical Trials of Rapid-Acting Psychotropic Interventional Drugs (RAPIDs) (R01 Clinical Trial Required)
National Institutes of Health
Amount
$5,000,000 total
Deadline
October 11, 2026
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 14, 2026
Ready to apply for Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities. Now let's win it.